Three-Statement Breakdown
LITTLE CHANGED
Revenue was little changed at $4.0B year over year, and carried a -3.6% net margin.
REVENUE
-0.9%
4,015
GROSS PROFIT
—
—
NET INCOME
—
-144
EPS (DILUTED)
—
-$2.91
| Income statement | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
|
2,266 | 2,621 | 2,924 | 3,540 | 3,976 | 4,129 | 4,050 | 4,015 | -0.9% |
| Gross profit |
NOT DISCLOSED
|
840 | 958 | 1,074 | — | — | — | — | — | — |
| SG&A |
|
(444) | (518) | (529) | (620) | (665) | (748) | (751) | (743) | -1.1% |
| Operating income |
|
331 | 351 | 433 | 590 | 651 | 617 | 227 | 25 | -88.9% |
| Interest expense |
|
(64) | (61) | (86) | (74) | (59) | (137) | (126) | (107) | -15.3% |
| Income tax |
|
(54) | (50) | (82) | (82) | (130) | (101) | (68) | (43) | -37.1% |
| Net income |
|
226 | 252 | 364 | 391 | 486 | 475 | 22 | -144 | — |
| EPS (diluted) |
|
$4.62 | $5.07 | $7.20 | $7.60 | $9.48 | $9.22 | $0.20 | -$2.91 | — |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-08-05 ↗